Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)485-498
Number of pages14
JournalBreast Cancer Research and Treatment
Volume165
Issue number3
DOIs
Publication statusPublished - Oct 2017

Keywords

  • Breast neoplasms
  • Neoplasm metastasis
  • Models
  • Economic
  • Cost-benefit analysis
  • Quality-adjusted life-years
  • Review
  • COST-EFFECTIVENESS ANALYSIS
  • LAPATINIB PLUS LETROZOLE
  • ECONOMIC-EVALUATION
  • UTILITY ANALYSIS
  • AROMATASE INHIBITORS
  • HORMONAL THERAPIES
  • 1ST-LINE TREATMENT
  • MODEL
  • TRASTUZUMAB
  • PACLITAXEL

Cite this

@article{0e612137c25944598d311c0c53f361ef,
title = "Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer",
keywords = "Breast neoplasms, Neoplasm metastasis, Models, Economic, Cost-benefit analysis, Quality-adjusted life-years, Review, COST-EFFECTIVENESS ANALYSIS, LAPATINIB PLUS LETROZOLE, ECONOMIC-EVALUATION, UTILITY ANALYSIS, AROMATASE INHIBITORS, HORMONAL THERAPIES, 1ST-LINE TREATMENT, MODEL, TRASTUZUMAB, PACLITAXEL",
author = "Pouwels, {Xavier Ghislain Leon Victor} and Ramaekers, {Bram L. T.} and Joore, {Manuela A.}",
year = "2017",
month = "10",
doi = "10.1007/s10549-017-4374-6",
language = "English",
volume = "165",
pages = "485--498",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer, Cham",
number = "3",

}

TY - JOUR

T1 - Reviewing the quality, health benefit and value for money of chemotherapy and targeted therapy for metastatic breast cancer

AU - Pouwels, Xavier Ghislain Leon Victor

AU - Ramaekers, Bram L. T.

AU - Joore, Manuela A.

PY - 2017/10

Y1 - 2017/10

KW - Breast neoplasms

KW - Neoplasm metastasis

KW - Models

KW - Economic

KW - Cost-benefit analysis

KW - Quality-adjusted life-years

KW - Review

KW - COST-EFFECTIVENESS ANALYSIS

KW - LAPATINIB PLUS LETROZOLE

KW - ECONOMIC-EVALUATION

KW - UTILITY ANALYSIS

KW - AROMATASE INHIBITORS

KW - HORMONAL THERAPIES

KW - 1ST-LINE TREATMENT

KW - MODEL

KW - TRASTUZUMAB

KW - PACLITAXEL

U2 - 10.1007/s10549-017-4374-6

DO - 10.1007/s10549-017-4374-6

M3 - Review article

VL - 165

SP - 485

EP - 498

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 3

ER -